These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25956695)

  • 21. Impact of enzalutamide and its main metabolite N-desmethyl enzalutamide on pharmacokinetically important drug metabolizing enzymes and drug transporters.
    Weiss J; Kocher J; Mueller C; Rosenzweig S; Theile D
    Biopharm Drug Dispos; 2017 Dec; 38(9):517-525. PubMed ID: 28865089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of the Absorption, Distribution, Metabolism, and Excretion of Lobeglitazone, a Novel Activator of Peroxisome Proliferator-Activated Receptor Gamma in Rats.
    Lee JH; Noh CK; Yim CS; Jeong YS; Ahn SH; Lee W; Kim DD; Chung SJ
    J Pharm Sci; 2015 Sep; 104(9):3049-59. PubMed ID: 25648999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and Safety of Enzalutamide in Healthy Chinese Male Volunteers.
    Liu YM; Wu P; Fukushi R; Yamada S; Chen Q
    Clin Ther; 2019 Feb; 41(2):261-268. PubMed ID: 30642613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved oral bioavailability in rats of SR13668, a novel anti-cancer agent.
    Green CE; Swezey R; Bakke J; Shinn W; Furimsky A; Bejugam N; Shankar GN; Jong L; Kapetanovic IM
    Cancer Chemother Pharmacol; 2011 May; 67(5):995-1006. PubMed ID: 20623225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic characterization of 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone, a novel 11β-hydroxysteroid dehydrogenase type 1 inhibitor in rats.
    Zheng Z; Seo H; Kwak HJ; Kim KY; Ahn JH; Bae MA; Song JS
    Arch Pharm Res; 2016 Apr; 39(4):492-498. PubMed ID: 26780247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide.
    Benoist GE; Hendriks RJ; Mulders PF; Gerritsen WR; Somford DM; Schalken JA; van Oort IM; Burger DM; van Erp NP
    Clin Pharmacokinet; 2016 Nov; 55(11):1369-1380. PubMed ID: 27106175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single- and repeated-dose pharmacokinetics of eplerenone, a selective aldosterone receptor blocker, in rats.
    Cook CS; Zhang L; Ames GB; Fischer J; Zhang J; Levin S
    Xenobiotica; 2003 Mar; 33(3):305-21. PubMed ID: 12637247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, pharmacodynamics and metabolism of a novel anticancer agent for prostate cancer.
    Yang J; Ahn S; Wu Z; Hwang DJ; Miller DD; Dalton JT
    Int J Oncol; 2012 Jul; 41(1):337-44. PubMed ID: 22576690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.
    Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B
    Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of magnolin in rats.
    Kim NJ; Song WY; Yoo SD; Oh SR; Lee HK; Lee HS
    Arch Pharm Res; 2010 Jun; 33(6):933-8. PubMed ID: 20607499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative determination of enzalutamide, an anti-prostate cancer drug, in rat plasma using liquid chromatography-tandem mass spectrometry, and its application to a pharmacokinetic study.
    Song JH; Kim TH; Jung JW; Kim N; Ahn SH; Hwang SO; Kang NS; Yoo SE; Koo TS
    Biomed Chromatogr; 2014 Aug; 28(8):1112-7. PubMed ID: 24424891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Gender on the Pharmacokinetics of ON 123300, A Dual Inhibitor of ARK5 and CDK4/6 for the Treatment of Cancer, in Rats.
    Mudunuru J; Ren C; Taft DR; Maniar M
    Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):531-538. PubMed ID: 30701428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Nonclinical Pharmacokinetics and Prediction of Human Pharmacokinetics of SPH3127, a Novel Direct Renin Inhibitor.
    Zhang L; Mao Y; Gao Z; Chen X; Li X; Liu Y; Xia G
    Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):15-26. PubMed ID: 31494843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic and ocular pharmacokinetics of N-4-benzoylaminophenylsulfonylglycine (BAPSG), a novel aldose reductase inhibitor.
    Sunkara G; Ayalasomayajula SP; Rao CS; Vennerstrom JL; DeRuiter J; Kompella UB
    J Pharm Pharmacol; 2004 Mar; 56(3):351-8. PubMed ID: 15025860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low oral bioavailability and pharmacokinetics of senkyunolide a, a major bioactive component in Rhizoma Chuanxiong, in the rat.
    Yan R; Lin G; Ko NL; Tam YK
    Ther Drug Monit; 2007 Feb; 29(1):49-56. PubMed ID: 17304150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics, Distribution, Metabolism, and Excretion of Omadacycline following a Single Intravenous or Oral Dose of 14C-Omadacycline in Rats.
    Lin W; Flarakos J; Du Y; Hu W; He H; Mangold J; Tanaka SK; Villano S
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-dependent pharmacokinetics of a new Na+/H+ exchanger inhibitor KR-33028 in rats.
    Kim YH; Yoo SD; Kim YS; Lee KH; Lee HS
    Biopharm Drug Dispos; 2007 Nov; 28(8):423-9. PubMed ID: 17828714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
    Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
    Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of O6-benzylguanine in rats and its metabolism by rat liver microsomes.
    Roy SK; Gupta E; Dolan ME
    Drug Metab Dispos; 1995 Dec; 23(12):1394-9. PubMed ID: 8689950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.